Wednesday, April 24, 11:00 am – 12:30 pm
Auditorium Lindbergh
Chairs: Suzanne S. Gisbertz (Netherlands) – Afrin N. Kamal (USA)
- Mechanisms by which topical alginates preserve esophageal epithelial barrier function during pepsin-weak acid insult – Pelin Ergun (USA)
- A novel antireflux procedure for management of gastroesophageal reflux disease: Clinical outcomes of 28 patients treated in Germany – Moustafa Elshafei (Germany)
- Diagnostic Yield for Clinically Relevant Abnormal Esophagogastric Junction Opening on Functional Lumen Imaging Probe (FLIP) at 60 mL and 70 mL Distention of 16-cm Balloon: A Case for Routine Measurement to 70 mL – Ryan Flanagan (USA)
- Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection – use of a novel symptom response questionnaire – Mickael Chevallay (Switzerland)
- The tumor microenvironment of esophageal cancer is influenced by clinical parameters and neoadjuvant treatment – Styliani Mantziari (Switzerland)
- Unveiling the Link Between Balanced and Plant-Based Diets and Esophageal Cancer: Insights from a Chinese Population-Based Cohort Study – Shanrui Ma (China)
- Fibrin sealant for prophylaxis of cervical anastomotic leakage after McKeown esophagectomy for esophageal or esophagogastric junction cancer(PLACE030): A Phase III, Multicenter, Randomized Clinical Trial – Zhichao Li (China)
- In silico validation and algorithm development of a novel tool for clinical outcome improvement of Barrett’s Esophagus malignant progression – Joana Cardoso (Portugal)